Skip to main content
logo
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.000
+0.080 (2.74%)
Jul 31, 2026, 4:08 PM HKT

HKG:1541 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
154.29154.2974.157.75.6913.81
Revenue Growth
25.61%108.09%863.60%35.24%-58.79%-
Gross Profit
153.18153.1874.157.75.6913.81
Operating Income
-223.04-223.04-313.43-364.67-364.45-210.47
Net Income
-218.58-218.58-315.86-379.46-402.89-732.95
Earnings Per Share
-0.53-0.53-0.84-1.05-1.21-8.50
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
United States of America
154.2154.274.01--
PRC
0.10.10.140.390.54
Total
154.29154.2974.150.390.54

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0161,016752.12608.56635.21668.33
Total Debt
228.03228.03136.3674.7714.6218.54
Net Cash (Debt)
788788615.76533.79620.59649.79
Net Cash Growth
43.28%27.97%15.36%-13.99%-4.49%-
Net Cash Per Share
1.911.911.631.481.877.54

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-202.58-202.58-128.04-367.55-238.71-190.54
Capital Expenditures
-1.31-1.31-10.4-2.69-23.22-40.7
Free Cash Flow
-203.9-203.9-138.44-370.25-261.93-231.24
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
99.28%99.28%100.00%100.00%100.00%100.00%
Operating Margin
-144.55%-144.55%-422.70%-4739.09%-6405.13%-1524.23%
Pretax Margin
-142.10%-142.10%-426.96%-4931.24%-7080.74%-5308.15%
Profit Margin
-141.66%-141.66%-425.97%-4931.24%-7080.74%-5308.15%
FCF Margin
-132.15%-132.15%-186.70%-4811.50%-4603.41%-1674.69%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
7.5414.6526.641319.67--